Announcements Trials
Browse Landscape

Status

Suspended 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Gynecologic 1Breast 1

Conditions

Lung Neoplasms 65Carcinoma, Non-Small-Cell Lung 46Neoplasms 9Breast Neoplasms 9Melanoma 7Head and Neck Neoplasms 7Ovarian Neoplasms 6Colorectal Neoplasms 5Small Cell Lung Carcinoma 4Uterine Cervical Neoplasms 3Urinary Bladder Neoplasms 3Pancreatic Neoplasms 3Neoplastic Cells, Circulating 3Neoplasm Metastasis 3Mesothelioma 3Kidney Neoplasms 3Esophageal Neoplasms 3Stomach Neoplasms 2Sarcoma 2Plaque, Atherosclerotic 2Liver Neoplasms 2Endometrial Neoplasms 2Disease 2Colonic Neoplasms 2Bronchitis, Chronic 2Adenocarcinoma 2Vulvar Neoplasms 1Uterine Neoplasms 1Urologic Neoplasms 1Thyroid Neoplasms 1

Interventions

Trastuzumab 2trastuzumab deruxtecan 1tipifarnib 1pembrolizumab 1entinostat 1Ritonavir 1Radiotherapy 1Quality of Life 1Patient Reported Outcome Measures 1Observation 1Nivolumab 1Molecular Diagnostic Techniques 1Interleukin-12 Subunit p35 1Interleukin-12 1Indinavir 1Immunotherapy 1Immunohistochemistry 1Fentanyl 1Drug Therapy 1Blood Specimen Collection 1Biopsy 1Biological Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Vulvar Neoplasms × Blood Specimen Collection × Thoracic × Clear all
NCT03987555 2026-03-18

Paclitaxel Therapeutic Drug Monitoring in Cancer Patients

Wake Forest University Health Sciences

Suspended
22 enrolled
BreastGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Lung Neoplasms, Ovarian Neoplasms, Uterine Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡